Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
Clinical trial NCT05028569 · TERMINATED
Trial details
- NCT number
- NCT05028569
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-11-06
- Enrollment
- 775
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.